| Patent | Date |
|---|
Levodopa fractionated dose composition and use
Grant 11,439,613 - Chase , et al. September 13, 2 | 2022-09-13 |
Alpha-synuclein Assays
App 20220214360 - CHASE; Thomas N. ; et al. | 2022-07-07 |
Nk-1 Antagonist Compositions And Methods For Use In Treating Depression
App 20220168281 - CHASE; Thomas N. ; et al. | 2022-06-02 |
Nk-1 Antagonist Compositions And Methods For Use In Treating Depression
App 20220160683 - CHASE; Thomas N. ; et al. | 2022-05-26 |
Pharmaceutical combination and its use for treating synucleinopathties
Grant 11,318,122 - Chase , et al. May 3, 2 | 2022-05-03 |
Domperidone Compositions And Methods For Treating Depression
App 20220071976 - CHASE; Thomas N. ; et al. | 2022-03-10 |
NK-1 antagonist compositions and methods for use in treating depression
Grant 11,266,633 - Chase , et al. March 8, 2 | 2022-03-08 |
Domperidone Antineurodegenerative Combinations And Use
App 20220000854 - CHASE; Thomas N. ; et al. | 2022-01-06 |
Anti-neurodegenerative Combinations And Use For Treatment Of Neurodegenerative Diseases
App 20210393595 - CHASE; Thomas N. ; et al. | 2021-12-23 |
Composition And Use For The Treatment Of Parkinson's Disease And Related Disorders
App 20210338652 - CHASE; Thomas N. ; et al. | 2021-11-04 |
NK1-antagonist combination and method for treating synucleinopathies
Grant 11,160,809 - Chase , et al. November 2, 2 | 2021-11-02 |
Levodopa Fractionated Dose Composition And Use
App 20210220308 - CHASE; Thomas N. ; et al. | 2021-07-22 |
Levodopa fractionated dose composition and use
Grant 11,033,521 - Chase , et al. June 15, 2 | 2021-06-15 |
Cell therapy for the treatment of neurodegeneration
Grant 10,874,723 - Chase , et al. December 29, 2 | 2020-12-29 |
Methods For Developing Pharmaceuticals For Treating Neurodegenerative Conditions
App 20200400687 - CHASE; Thomas N. ; et al. | 2020-12-24 |
Compositions And Methods For Treating Synucleinopathies
App 20200397761 - Chase; Thomas N. ; et al. | 2020-12-24 |
Pharmaceutical Combination And Its Use For Treating Synucleinopathies
App 20200375956 - CHASE; Thomas N. ; et al. | 2020-12-03 |
Compositions And Method For Treating Depression
App 20200375957 - CHASE; Thomas N. ; et al. | 2020-12-03 |
Compositions and methods for treating synucleinopathies
Grant 10,799,484 - Chase , et al. October 13, 2 | 2020-10-13 |
Memantine Combinations And Use
App 20200253893 - Kind Code | 2020-08-13 |
Oxybutynin-xanomeline Transdermal Therapeutic System Combinations
App 20200171014 - Chase; Thomas N. ; et al. | 2020-06-04 |
Nk-1 Antagonist Compositions And Methods For Use In Treating Depression
App 20200147053 - CHASE; Thomas N. ; et al. | 2020-05-14 |
Nk1-antagonist Combination And Method For Treating Synucleinopathies
App 20200147097 - CHASE; Thomas N ; et al. | 2020-05-14 |
Pharmaceutical Combinations Of Zonisamide And Pramipexole, And Related Methods, For Treating Synucleinopathies
App 20200138792 - CHASE; Thomas N. ; et al. | 2020-05-07 |
Levodopa Fractionated Dose Composition And Use
App 20200121626 - CHASE; Thomas N. ; et al. | 2020-04-23 |
Method And Composition For Treating Alzheimer-type Dementia
App 20200121656 - CHASE; Thomas N. ; et al. | 2020-04-23 |
Statin Compositions And Methods For Use In Treating Synucleinopathies
App 20200113899 - CHASE; Thomas N. ; et al. | 2020-04-16 |
Oxybutynin transdermal therapeutic system muscarinic agonist combination
Grant 10,596,139 - Chase , et al. | 2020-03-24 |
Memantine combinations and use
Grant 10,548,855 - Clarence-Smith , et al. Fe | 2020-02-04 |
Compositions And Methods For Treating Synucleinopathies
App 20200016127 - CHASE; Thomas N. ; et al. | 2020-01-16 |
Anticholinergic Neuroprotective Composition And Methods
App 20190365736 - CLARENCE-SMITH; Kathleen E. ; et al. | 2019-12-05 |
Muscarinic Combinations And Their Use For Combating Hypocholinergic Disorders Of The Central Nervous System
App 20190314354 - CHASE; Thomas N. ; et al. | 2019-10-17 |
Memantine Combinations And Use
App 20190269627 - CLARENCE-SMITH; Kathleen E. ; et al. | 2019-09-05 |
Muscarinic combinations and their use for combating hypocholinergic disorders of the central nervous system
Grant 10,307,409 - Chase , et al. | 2019-06-04 |
Use And Composition For Treating Dementia
App 20190091214 - Chase; Thomas N. ; et al. | 2019-03-28 |
Oxybutynin-xanomeline transdermal therapeutic system combinations
Grant 10,195,187 - Chase , et al. Fe | 2019-02-05 |
Anticholinergic Neuroprotective Composition And Methods
App 20190000826 - Clarence-Smith; Kathleen E. ; et al. | 2019-01-03 |
Muscarinic Combination Of A Selective M2-antagonist And A Peripheral Non-selective Antagonist For Treating Hypocholinergic Disorders
App 20180360845 - CHASE; Thomas N. ; et al. | 2018-12-20 |
Cell Therapy For The Treatment Of Neurodegeneration
App 20180353577 - CHASE; Thomas N. ; et al. | 2018-12-13 |
Cell therapy for the treatment of neurodegeneration
Grant 10,149,894 - Chase , et al. Dec | 2018-12-11 |
Oxybutynin transdermal therapeutic system combination
Grant 10,149,828 - Chase , et al. Dec | 2018-12-11 |
Method And Composition For Treating Alzheimer-type Dementia
App 20180296540 - CHASE; Thomas N. ; et al. | 2018-10-18 |
Cell therapy for the treatment of neurodegeneration
Grant 10,071,144 - Sasaki , et al. September 11, 2 | 2018-09-11 |
Muscarinic Combination And Its Use For Combating Hypocholinergic Disorders Of The Central Nervous System
App 20180250270 - CHASE; Thomas N. ; et al. | 2018-09-06 |
Memantine Combinations And Use
App 20180116979 - CLARENCE-SMITH; Kathleen E. ; et al. | 2018-05-03 |
Method and composition for treating Alzheimer-type dementia
Grant 9,943,508 - Chase , et al. April 17, 2 | 2018-04-17 |
Anticholinergic neuroprotective composition and methods
Grant 9,913,836 - Clarence-Smith , et al. March 13, 2 | 2018-03-13 |
Oxybutynin-xanomeline Transdermal Therapeutic System Combinations
App 20180050023 - CHASE; Thomas N. ; et al. | 2018-02-22 |
Oxybutynin Transdermal Therapeutic System Muscarinic Agonist Combination
App 20180050008 - CHASE; Thomas N. ; et al. | 2018-02-22 |
Peripheral-anticholinergic Muscarinic Agonist Combination
App 20180050018 - CLARENCE-SMITH; Kathleen E. ; et al. | 2018-02-22 |
Piperidinium quaternary salts
Grant 9,896,416 - Clarence-Smith , et al. February 20, 2 | 2018-02-20 |
Cell Therapy For The Treatment Of Neurodegeneration
App 20170326211 - CHASE; Thomas N. ; et al. | 2017-11-16 |
Method And Composition For Treating Alzheimer-type Dementia
App 20170312259 - CHASE; Thomas N. ; et al. | 2017-11-02 |
Method and composition for treating alzheimer-type dementia
Grant 9,744,161 - Chase , et al. August 29, 2 | 2017-08-29 |
Anticholinergic Neuroprotective Composition And Methods
App 20170087142 - CLARENCE-SMITH; Kathleen E. ; et al. | 2017-03-30 |
Anticholinergic neuroprotective composition and methods
Grant 9,561,218 - Clarence-Smith , et al. February 7, 2 | 2017-02-07 |
Muscarinic Combinations And Their Use For Combating Hypocholinergic Disorders Of The Central Nervous System
App 20160375001 - CHASE; Thomas N. ; et al. | 2016-12-29 |
Oxybutynin Transdermal Therapeutic System Combination
App 20160243070 - CHASE; Thomas N. ; et al. | 2016-08-25 |
Method And Composition For Treating Alzheimer-type Dementia
App 20160143890 - CHASE; Thomas N. ; et al. | 2016-05-26 |
Method and composition for treating alzheimer-type dementia
Grant 9,278,092 - Chase , et al. March 8, 2 | 2016-03-08 |
Method and composition for treating alzheimer-type dementia
Grant 9,192,591 - Chase , et al. November 24, 2 | 2015-11-24 |
Anticholinergic Neuroprotective Composition And Methods
App 20150231122 - Clarence-Smith; Kathleen E. ; et al. | 2015-08-20 |
Use And Composition For Treating Dementia
App 20150224096 - CHASE; Thomas N. ; et al. | 2015-08-13 |
Piperidinium Quaternary Salts
App 20150203452 - Clarence-Smith; Kathleen E. ; et al. | 2015-07-23 |
Use and composition for treating dementia
Grant 9,044,472 - Chase , et al. June 2, 2 | 2015-06-02 |
Method And Composition For Treating Alzheimer-type Dementia
App 20150005292 - CHASE; Thomas N. ; et al. | 2015-01-01 |
Composition For Treating Parkinson's Disease
App 20140356343 - Chase; Thomas N. ; et al. | 2014-12-04 |
Method and composition for treating alzheimer-type dementia
Grant 8,877,768 - Chase , et al. November 4, 2 | 2014-11-04 |
Method And Composition For Treating Alzheimer-type Dementia
App 20140288057 - CHASE; Thomas N. ; et al. | 2014-09-25 |
Use And Composition For Treating Dementia
App 20140275036 - CHASE; Thomas N. ; et al. | 2014-09-18 |
Cell Therapy For The Treatment Of Neurodegeneration
App 20140219969 - Sasaki; Keishin ; et al. | 2014-08-07 |
Use And Composition For Treating Dementia
App 20130158012 - Chase; Thomas N. ; et al. | 2013-06-20 |
Use and composition for treating dementia
Grant 8,404,701 - Chase , et al. March 26, 2 | 2013-03-26 |
Method And Composition For Treating Alzheimer-type Dementia
App 20110201597 - CHASE; Thomas N. ; et al. | 2011-08-18 |
Method And Composition For Treating Alzheimer-type Dementia
App 20110071135 - CHASE; Thomas N. ; et al. | 2011-03-24 |
Use And Composition For Treating Dementia
App 20110021503 - Chase; Thomas N. ; et al. | 2011-01-27 |
| 